Cargando…

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

Detalles Bibliográficos
Autores principales:	Härmark, Linda, Weits, Gerda, Meijer, Rietje, Santoro, Federica, Norén, G. Niklas, van Hunsel, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395902/ https://www.ncbi.nlm.nih.gov/pubmed/32617875 http://dx.doi.org/10.1007/s40264-020-00970-z

Ejemplares similares

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes
por: Rolfes, Leàn, et al.
Publicado: (2022)

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
por: Rolfes, Leàn, et al.
Publicado: (2016)

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
por: Scholl, Joep H.G., et al.
Publicado: (2017)

Adverse drug reactions of montelukast in children and adults
por: Haarman, Meindina G., et al.
Publicado: (2017)

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
por: Sartori, Daniele, et al.
Publicado: (2022)

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
por: de Vries, Sieta T., et al.
Publicado: (2021)

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
por: Ekhart, Corine, et al.
Publicado: (2022)

Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports
por: Watson, Sarah, et al.
Publicado: (2018)

Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis
por: van Hoof, Monica, et al.
Publicado: (2022)

Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana
por: Sabblah, George Tsey, et al.
Publicado: (2019)

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands
por: van der Boor, Saskia C., et al.
Publicado: (2023)

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre
por: Watson, Sarah, et al.
Publicado: (2017)

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
por: Rolfes, Leàn, et al.
Publicado: (2017)

Correction to: vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues
por: Bergvall, Tomas, et al.
Publicado: (2019)

Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb
por: Vrolijk, Misha F., et al.
Publicado: (2020)

Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre
por: Habarugira, Jean Marie Vianney, et al.
Publicado: (2021)

Time to onset in statistical signal detection revisited: A follow‐up study in long‐term onset adverse drug reactions
por: Scholl, Joep H.G., et al.
Publicado: (2019)

Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Kant, Agnes, et al.
Publicado: (2022)

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
por: Sandberg, Lovisa, et al.
Publicado: (2020)

Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
por: DAVIDSON, Linda, et al.
Publicado: (2022)

Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
por: Ballow, Mark, et al.
Publicado: (2018)

Correction to: Adverse drug reactions in older adults: a narrative review of the literature
por: Zazzara, Maria Beatrice, et al.
Publicado: (2021)

Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study
por: Oosterhuis, Ingrid, et al.
Publicado: (2018)

Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands
por: Kant, Agnes, et al.
Publicado: (2022)

Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting
por: Iwasa, Eiko, et al.
Publicado: (2020)

Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization
por: King, Charlotte, et al.
Publicado: (2020)

Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands
por: Dittrich, Anne T. M., et al.
Publicado: (2020)

Correction: Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
por: Eluwa, George I, et al.
Publicado: (2012)

Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study
por: de Heus, Roel, et al.
Publicado: (2009)

Correction: Do Longer Intervals between Challenges Reduce the Risk of Adverse Reactions in Oral Wheat Challenges?
por: Yanagida, Noriyuki, et al.
Publicado: (2015)

Correction: Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma
Publicado: (2014)

Correction: Structural Insights into Streptococcal Competence Regulation by the Cell-to-Cell Communication System ComRS
por: Talagas, Antoine, et al.
Publicado: (2017)

Correction: Biodiversity Assessment of the Fishes of Saba Bank Atoll, Netherlands Antilles
por: Williams, Jeffrey T., et al.
Publicado: (2010)

Correction: Biodiversity Assessment of the Fishes of Saba Bank Atoll, Netherlands Antilles
por: Williams, Jeffrey T., et al.
Publicado: (2010)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
por: Onakpoya, Igho J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_36k6igcutrhefs1u2g2ufjqei7